BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29039348)

  • 41. Pin1-Targeted Therapy for Systemic Lupus Erythematosus.
    Wei S; Yoshida N; Finn G; Kozono S; Nechama M; Kyttaris VC; Zhen Zhou X; Tsokos GC; Ping Lu K
    Arthritis Rheumatol; 2016 Oct; 68(10):2503-13. PubMed ID: 27159270
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of anti-CD4 antibodies on the release of IL-6 and TNF-alpha in whole blood samples from patients with systemic lupus erythematosus.
    Brink I; Thiele B; Burmester GR; Trebeljahr G; Emmrich F; Hiepe F
    Lupus; 1999; 8(9):723-30. PubMed ID: 10602444
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus.
    Horwitz DA; Gray JD; Behrendsen SC; Kubin M; Rengaraju M; Ohtsuka K; Trinchieri G
    Arthritis Rheum; 1998 May; 41(5):838-44. PubMed ID: 9588735
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Toll-like receptor expression in lupus peripheral blood mononuclear cells.
    Migita K; Miyashita T; Maeda Y; Nakamura M; Yatsuhashi H; Kimura H; Ishibashi H; Eguchi K
    J Rheumatol; 2007 Mar; 34(3):493-500. PubMed ID: 17295441
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Toll-like receptor 9 in systemic lupus erythematosus, impact on glucocorticoid treatment.
    Ghaly NR; Kotb NA; Nagy HM; Rageh el SM
    J Dermatolog Treat; 2013 Dec; 24(6):411-7. PubMed ID: 22620859
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.
    Talaat RM; Mohamed SF; Bassyouni IH; Raouf AA
    Cytokine; 2015 Apr; 72(2):146-53. PubMed ID: 25647269
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Abnormal signaling activity of phosphatidylinositol 3-kinase pathway in peripheral blood T cells from patients with systemic lupus erythematosus].
    Liang LQ; Zhan ZP; Xu HS; Yang XY; Ye YJ; Lian F; Qiu Q
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(29):2036-40. PubMed ID: 19080430
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of calcitonin gene-related peptide on apoptosis of peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
    Liu C; Chen X; Jin Y; Qu R; Jiang PF; Wen GM; Tang ZH
    Clin Exp Dermatol; 2007 Nov; 32(6):650-3. PubMed ID: 17725664
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhanced interferon regulatory factor 3 binding to the interleukin-23p19 promoter correlates with enhanced interleukin-23 expression in systemic lupus erythematosus.
    Smith S; Gabhann JN; Higgs R; Stacey K; Wahren-Herlenius M; Espinosa A; Totaro MG; Sica A; Ball E; Bell A; Johnston J; Browne P; O'Neill L; Kearns G; Jefferies CA
    Arthritis Rheum; 2012 May; 64(5):1601-9. PubMed ID: 22127978
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relation between soluble interleukin 2 receptor and clinical findings in patients with systemic lupus erythematosus.
    Tokano Y; Murashima A; Takasaki Y; Hashimoto H; Okumura K; Hirose S
    Ann Rheum Dis; 1989 Oct; 48(10):803-9. PubMed ID: 2818016
    [TBL] [Abstract][Full Text] [Related]  

  • 51. IgE Inhibits Toll-like Receptor 7- and Toll-like Receptor 9-Mediated Expression of Interferon-α by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus.
    Khoryati L; Augusto JF; Shipley E; Contin-Bordes C; Douchet I; Mitrovic S; Truchetet ME; Lazaro E; Duffau P; Couzi L; Jacquemin C; Barnetche T; Vacher P; Schaeverbeke T; Blanco P; Richez C;
    Arthritis Rheumatol; 2016 Sep; 68(9):2221-31. PubMed ID: 26991804
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus.
    Wang H; Xu J; Ji X; Yang X; Sun K; Liu X; Shen Y
    Cell Immunol; 2005 Jun; 235(2):117-21. PubMed ID: 16226734
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of pathogenic auto-antibody production by Toll-like receptor 9 of B cells in active systemic lupus erythematosus.
    Nakano S; Morimoto S; Suzuki J; Nozawa K; Amano H; Tokano Y; Takasaki Y
    Rheumatology (Oxford); 2008 Feb; 47(2):145-9. PubMed ID: 18160420
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased Toll-Like Receptors Activity and TLR Ligands in Patients with Autoimmune Thyroid Diseases.
    Peng S; Li C; Wang X; Liu X; Han C; Jin T; Liu S; Zhang X; Zhang H; He X; Xie X; Yu X; Wang C; Shan L; Fan C; Shan Z; Teng W
    Front Immunol; 2016; 7():578. PubMed ID: 28018345
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Soluble interleukin 2 receptor levels in serum and its relationship to T cell abnormality and clinical manifestations of the disease in patients with systemic lupus erythematosus.
    Raziuddin S; al-Janadi MA; al-Wabel AA
    J Rheumatol; 1991 Jun; 18(6):831-6. PubMed ID: 1680190
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dasatinib inhibits the secretion of TNF-alpha following TLR stimulation in vitro and in vivo.
    Fraser CK; Lousberg EL; Kumar R; Hughes TP; Diener KR; Hayball JD
    Exp Hematol; 2009 Dec; 37(12):1435-44. PubMed ID: 19786067
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Polymorphisms within Toll-like receptors are associated with systemic lupus erythematosus in a cohort of Danish females.
    Laska MJ; Troldborg A; Hansen B; Stengaard-Pedersen K; Junker P; Nexø BA; Voss A
    Rheumatology (Oxford); 2014 Jan; 53(1):48-55. PubMed ID: 24064706
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The changes of T lymphocyte subsets and serum interleukin-2 receptor in peripheral blood of the pregnant women complicated by systemic lupus erythematosus].
    Su Y; Hong S; Zhao A
    Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):671-3. PubMed ID: 9639769
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epratuzumab inhibits the production of the proinflammatory cytokines IL-6 and TNF-α, but not the regulatory cytokine IL-10, by B cells from healthy donors and SLE patients.
    Fleischer V; Sieber J; Fleischer SJ; Shock A; Heine G; Daridon C; Dörner T
    Arthritis Res Ther; 2015 Jul; 17(1):185. PubMed ID: 26183319
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Serum soluble interleukin 2 receptor levels in patients with diffuse connective tissue diseases].
    Sun HY; Liu WL; Xiu HZ
    Zhonghua Nei Ke Za Zhi; 1993 Aug; 32(8):528-30. PubMed ID: 8269781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.